From the Wires
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Young Innovations, Inc. (YDNT), Peregrine Pharmaceuticals, Inc. (PPHM) and Health Management Associates, Inc. (HMA)
By: PR Newswire
Dec. 4, 2012 08:11 PM
NEW YORK, Dec. 4, 2012 /PRNewswire/ --
Young Innovations, Inc.
Click here to learn more about the investigation: http://zlk.9nl.com/young-innovations-ydnt/, or call: 877-363-5972.
Peregrine Pharmaceuticals, Inc.
For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm/.
Health Management Associates, Inc.
For more information, click here: http://zlk.9nl.com/health-management-hma/.
On August 3, 2011, the Company announced that the U.S. Department of Health and Human Services (DHHS) had issued a subpoena requesting information concerning Health Management's physician referrals. As a result, shares in the Company's common stock dropped by $0.80, closing at $7.97 per share. Five months later, on January 9, 2012, an analyst from CRT Capital Group reported a lawsuit had been filed against the Company under Florida's Private Sector Whistleblower's Act by its former compliance director, Paul Meyer. Meyer alleges he was unlawfully terminated after reporting what he believed to be Medicare fraud, which also included fraudulent billing. Health Management's common stock fell yet again $0.53, dropping from $7.49 to $6.96 per share.
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE Levi & Korsinsky, LLP
Latest AJAXWorld RIA Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week